Case report: Long-lasting SARS-CoV-2 infection with post-COVID-19 condition in two patients with chronic lymphocytic leukemia: The emerging therapeutic role of casirivimab/imdevimab

Post-coronavirus disease 2019 (post-COVID-19) condition, previously referred to as long COVID, includes a post-acute syndrome defined by the presence of non-specific symptoms occurring usually 3 months from the onset of the acute phase and lasting at least 2 months. Patients with chronic lymphocytic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballotta, Laura, Simonetti, Omar, D’Agaro, Pierlanfranco, Segat, Ludovica, Koncan, Raffaella, Martinez-Orellana, Pamela, Dattola, Federica, Orsini, Emanuele, Marcello, Alessandro, Dal Monego, Simeone, Licastro, Danilo, Misin, Andrea, Mohamed, Sara, Sbisà, Eugenio, Lucchini, Elisa, De Sabbata, Giovanni Maria, Zaja, Francesco, Luzzati, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561900/
https://www.ncbi.nlm.nih.gov/pubmed/36249044
http://dx.doi.org/10.3389/fonc.2022.945060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561900/
https://www.ncbi.nlm.nih.gov/pubmed/36249044
http://dx.doi.org/10.3389/fonc.2022.945060

Ejemplares similares